A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/1992
11/12/1992	WO1992019209A2 Taste-masked medicaments and their preparation
11/12/1992	WO1992019195A1 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
11/12/1992	DE4212132A1 Propolisbestandteile enthaltendes feststoffprodukt, seine herstellung und verwendung Propolis-containing solid product, its production and use
11/12/1992	DE4115038A1 Neue konjugate, bestehend aus einem glykoprotein und einer nukleinsaeure-bindenden substanz New conjugate consisting of a glycoprotein and a nucleic acid-binding substance
11/12/1992	CA2109527A1 Amino-acid sequence homologies between selectins and b pertussis toxin-peptides derived therefrom, antibodies thereto and pharmaceutical compositions
11/12/1992	CA2108451A1 Novel antibodies, and methods for their use
11/11/1992	EP0512844A1 Targeted delivery of bone growth factors
11/11/1992	EP0512547A1 Pain controlling composition and method of preparation
11/11/1992	EP0512319A2 Process for preparing carbonic acid derivatives of polysaccharides
11/11/1992	EP0512104A1 Stabilized hexahydro-5-pyrimidinamine compounds in aqueous solution and methods for preparing same
11/11/1992	EP0512095A1 Methyl pyrrolidinone chitosan, production process and uses thereof.
11/11/1992	EP0512050A1 Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
11/11/1992	EP0409862B1 Topical preparations
11/11/1992	CN1065997A 疫苗 Vaccine
11/11/1992	CA2102808A1 Targeted delivery of bone growth factors
11/10/1992	US5162515 Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus
11/10/1992	US5162512 Treatment of cellular disorders
11/10/1992	US5162430 To a synthetic hydrophilic polymer, polyoxyethylene glycol; wound healing, slow release drug delivery
11/10/1992	US5162315 Penetration enhancers
11/10/1992	US5162307 Polymer bound elastase inhibitors
11/10/1992	US5162302 Thyroid Hormone, Growth Hormone Releasing Factor or Thyrotropin Releasing Hormone
11/10/1992	US5162218 Conjugated polypeptides and methods for their preparation
11/10/1992	US5162115 Antineoplastic solution and method for treating neoplasms
11/10/1992	US5162110 Sustained release composition
11/10/1992	US5162057 Coatings for stable sustained release preparations
11/10/1992	CA1309951C Press coated dhp tablets
11/10/1992	CA1309950C Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter
11/10/1992	CA1309949C Contraceptive implant
11/09/1992	CA2105771A1 New conjugates, consisting of a glycoprotein and a nucleic acid-binding substance
11/07/1992	WO1992019251A1 Combined calcium and vitamin d supplements
11/04/1992	WO1992019259A1 Interleukin receptor targeted molecules for treatment of inflammatory arthritis
11/04/1992	EP0511903A2 Conjugate of calcitonin and polyethylene glycol
11/04/1992	EP0511767A1 Tablets containing compound DUP753
11/04/1992	EP0511499A2 Method and catheter for controlled intravascular drug delivery
11/04/1992	EP0511317A1 Composition to improve survival of biological materials
11/04/1992	EP0511300A1 Monoclonal antibody specific for non-immunodominant epitope of hiv proteins
11/04/1992	EP0511292A1 Polyanhydrides of the oligomerized unsaturated aliphatic acids
11/04/1992	EP0511273A1 Liposomes as contrast agents for ultrasonic imaging
11/04/1992	EP0511234A1 Stable injectible solutions for factor viii.
11/04/1992	EP0191814B1 Protein absorption enhancing agents
11/04/1992	CA2108886A1 Interleukin receptor targeted molecules for treatment of inflammatory arthritis
11/03/1992	US5160741 Reduction or prevention of skin irritation by drugs
11/03/1992	US5160737 Acrylic copolymer; sustained release; dentistry, dermatology
11/03/1992	US5160734 Complex with polyoxyethylene-polyoxypropylene copolymer
11/03/1992	US5160725 Magnetic liquid compositions
11/03/1992	US5160680 Heating, extrusion
11/03/1992	US5160546 Artificial sweetener
11/03/1992	CA1309657C Biodegradable microspheres as a carrier for macromolecules
11/03/1992	CA1309656C Sustained-release drug preparation
11/02/1992	WO1992019230A1 Stabilized, aqueous, film-forming antimicrobial compositions of hydrogen peroxide
11/02/1992	CA2107780A1 Stabilized, aqueous, film-forming antimicrobial compositions of hydrogen peroxide
10/1992
10/30/1992	CA2067307A1 Optimized tablet formulation
10/29/1992	WO1992018610A2 Compositions and methods for endothelial binding
10/29/1992	WO1992018529A1 Increasing blood-brain barrier permeability with permeabilizer peptides
10/29/1992	WO1992018169A1 An organ specific emulsion
10/29/1992	WO1992018165A2 Improved fluorocarbon contrast media for use with mri and radiographic imaging
10/29/1992	WO1992018150A1 Mhc conjugates useful in ameliorating autoimmunity
10/29/1992	WO1992018147A1 Convertible microemulsion formulations
10/29/1992	WO1992018135A1 Compositions and methods for introducing effectors to pathogens and cells
10/29/1992	WO1992018110A1 Process for conditioning of water-soluble substances
10/29/1992	WO1992018105A1 Improvements in pharmaceutical compositions
10/29/1992	WO1992018104A1 Pharmaceutical formulation and process
10/29/1992	WO1992018102A1 Dosage forms comprising polymers comprising different molecular weights
10/29/1992	WO1992013570A3 Novel complexes containing nucleic acid which can be absorbed into higher eucaryotic cells via endocytosis
10/29/1992	CA2585487A1 Water-soluble polypeptides with strong affinity for .alpha. and .beta. interferons
10/29/1992	CA2109094A1 An organ specific emulsion
10/29/1992	CA2108786A1 Compositions and methods for endothelial binding
10/28/1992	EP0511181A1 Saliva substitute
10/28/1992	EP0511118A1 Use of lysine and or arginine pyrrolidone carboxylate as anti-oxydant agent in a cosmetic or pharmaceutical composition
10/28/1992	EP0511011A1 Novel antibodies and methods for their use
10/28/1992	EP0510949A2 Cytomodulating conjugates of members of specific binding pairs
10/28/1992	EP0510731A1 LHRH Analog formulations
10/28/1992	EP0510404A1 Gastroresistant pharmaceutical formulations for oral administration containing salts of bile acids
10/28/1992	EP0510356A1 Polyethylene glycol protein conjugates
10/28/1992	EP0510210A1 Procaterol-containing plaster
10/28/1992	EP0510186A1 Therapeutic uses of melanin
10/28/1992	EP0510165A1 Amphiphilic non-ionic, glycerol-derived compounds, a method for preparing same, corresponding intermediate compounds and compositions containing said compounds.
10/28/1992	EP0510132A1 Polymeric carriers for release of covalently linked agents.
10/28/1992	EP0510080A1 Prodrug anhydrides of asprin, indomethacin and ibuprofen, their preparation, compositions, and anti-inflammatory method of use
10/28/1992	EP0510074A1 Porphyrin derivatives and metalloporphyrins optionally coupled with a biologically active molecule, and pharmaceutical composition containing same
10/28/1992	EP0321499B1 Covalently bonded active agents with carbonium ion base groups
10/28/1992	EP0216860B1 Stereoregular polynucleotide-binding polymers
10/27/1992	US5159065 Soluble in chloroform, methanol; antitumor agent, viricides
10/27/1992	US5158977 Antioxidant; preventive treatment of cutaneous inflammations and allergies
10/27/1992	US5158944 Dispersed in excipient readily soluble in organic solvent, and basic substance
10/27/1992	US5158789 Melt cocrystallized sorbitol/xylitol compositions
10/27/1992	US5158778 Stable antimicrobial dialdehyde composition and methods of use
10/27/1992	US5158776 Includes microcrystalline cellulose
10/27/1992	US5158772 Beta-1,3-glucan-type polysaccharide
10/27/1992	US5158769 Genetic engineering; polypeptide protective coating for vaccine
10/27/1992	US5158768 Process for preparing a stable, low K-value, water-soluble PVP-iodine product
10/27/1992	US5158761 Spray gel base and spray gel preparation using thereof
10/27/1992	CA1309558C D-gl conjugate therapy
10/27/1992	CA1309348C Ophthalmic composition containing polysiloxane
10/27/1992	CA1309347C Delayed/sustained release of macromolecules
10/27/1992	CA1309345C Controlled release drug delivery system for the periodontal pocket
10/24/1992	CA2066810A1 Cytomodulating conjugates of members of specific binding pairs
10/23/1992	WO1992018163A1 Medicine for intraocular operation
10/23/1992	CA2085732A1 Pharmaceutical composition for use in intraocular surgery
10/22/1992	DE4112464A1 Verbesserte retard-systeme fuer die zeitverzoegerte freigabe medizinischer und/oder biologischer wertstoffe aus einem depot-traegermaterial Improved sustained-release systems for the zeitverzoegerte medical and / or biological reusable materials from a depot-traegermaterial

1 ... 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 1625 1626 ... 1712